Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma

J Virol. 1998 Jan;72(1):789-95. doi: 10.1128/JVI.72.1.789-795.1998.

Abstract

To generate transcriptionally targeted vectors, tissue-specific elements of the human tyrosinase promoter were exchanged with corresponding viral elements in the Moloney murine leukemia virus long terminal repeat (LTR). From these experiments, a vesicular stomatitis virus type G pseudotyped, hybrid LTR vector that contained three tyrosinase enhancer elements and gave high-level, tightly tissue-specific expression at high titers (3 x 10(7) CFU/ml) was constructed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Enhancer Elements, Genetic
  • Gene Targeting
  • Genes, Regulator
  • Genes, Viral
  • Genetic Therapy*
  • Genetic Vectors*
  • Humans
  • Leukemia Virus, Murine / genetics*
  • Melanoma / therapy*
  • Mice
  • Monophenol Monooxygenase / genetics
  • Promoter Regions, Genetic
  • Repetitive Sequences, Nucleic Acid
  • Tumor Cells, Cultured
  • Vesicular stomatitis Indiana virus / genetics

Substances

  • Monophenol Monooxygenase